Baylor College of Medicine
OrganisationROR
People
28 Sept 2026tigem.it
Professor22 Sept 2026reporter.nih.gov
14 Sept 2026reporter.nih.gov
16 Jul 2026reporter.nih.gov
Assistant professor7 Jul 2026reporter.nih.gov
Associate professor7 Jul 2026reporter.nih.gov
3 Jul 2026reporter.nih.gov
Professor30 Jun 2026reporter.nih.gov
Professor25 Jun 2026reporter.nih.gov
Assistant professor5 Jun 2026reporter.nih.gov
3 Jun 2026reporter.nih.gov
3 Jun 2026reporter.nih.gov
Associate professor3 Jun 2026reporter.nih.gov
1 Jun 2026reporter.nih.gov
25 May 2026reporter.nih.gov
Instructor22 May 2026reporter.nih.gov
Associate professor12 May 2026reporter.nih.gov
Professor and director12 May 2026reporter.nih.gov
Assistant professor12 May 2026reporter.nih.gov
Assistant professor8 May 2026reporter.nih.gov
Trials
Early phase 1Not yet recruiting202635 people29 Sept 2025clinicaltrials.gov
Phase 4Not yet recruiting202556 people31 May 2025clinicaltrials.gov
Novel Brain Stimulation Treatment for Neuropsychiatric Symptoms in Alzheimer's Disease
No phaseNot yet recruiting202620 people19 Feb 2025clinicaltrials.gov
Phase 2Recruiting202485 people13 Nov 2024clinicaltrials.gov
CollaboratorPhase 2Recruiting2024100 people22 Feb 2024clinicaltrials.gov
CollaboratorPhase 2Recruiting202634 people15 Feb 2024clinicaltrials.gov
CollaboratorPhase 1Not yet recruiting202612 people15 Feb 2024clinicaltrials.gov
CollaboratorPhase 2Completed202453 people15 Aug 2023clinicaltrials.gov
CollaboratorPhase 1/2Withdrawn20230 people17 Mar 2022clinicaltrials.gov
Phase 4Completed202013 people17 Aug 2021clinicaltrials.gov
Early phase 1Active, not recruiting202252 people5 Feb 2021clinicaltrials.gov
Early phase 1Terminated20214 people11 Jan 2021clinicaltrials.gov
CollaboratorPhase 3Completed2021114 people9 Jan 2020clinicaltrials.gov
Phase 2Completed201813 people17 Apr 2018clinicaltrials.gov
Early phase 1Active, not recruiting201860 people10 Apr 2018clinicaltrials.gov
Early phase 1Completed201737 people5 Dec 2016clinicaltrials.gov
Phase 1/2Completed201726 people31 Oct 2016clinicaltrials.gov
Phase 1Completed201622 people1 Sept 2016clinicaltrials.gov
Phase 4Terminated201517 people20 Nov 2015clinicaltrials.gov
CollaboratorPhase 1/2Active, not recruiting201650 people17 Sept 2015clinicaltrials.gov
Grants and prizes
R21SOMATIC EVOLUTION AND PRE-CANCER OF TP53 MUTANT CLONESR21CA317193US$429.2k2026–202822 Sept 2026reporter.nih.gov
The role of astrocytes in TRN dysfunction and sleep disruption in Alzheimer's diseaseF31AG091930US$50.1k14 Sept 2026reporter.nih.gov
R01Clonal competition between TP53 and PPM1D mutations in hematopoiesisR01CA237291US$679.6k2019–203116 Jul 2026reporter.nih.gov
National Institute of Neurological Disorders and Stroke
UH3Identification of somatic/ mosaic SV and transposon activity and their crosstalk to DNA epigenetic ModificationsUH3NS132105US$490k2023–20287 Jul 2026reporter.nih.gov
R01The Role of the Complement Pathway in Alzheimer's DiseaseR01AG088197US$780.9k2024–20293 Jul 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R35Impact of Infection and Inflammation on Primitive HematopoiesisR35HL155672US$844.2k2021–202830 Jun 2026reporter.nih.gov
R01Genetic Epidemiology of Hepatocellular Carcinoma in African AmericansR01CA274528US$366k2023–202825 Jun 2026reporter.nih.gov
R00Impact of DNA double-strand breaks on 3D genome organization and genome stability in Alzheimer's diseaseR00AG073466US$249k2021–20275 Jun 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01Induction of Cardiomyocyte Proliferation via Transient Expression of Cell Cycle Factors as a Promising Therapy for Heart FailureR01HL147921US$704.5k2020–20293 Jun 2026reporter.nih.gov
National Institute of Diabetes and Digestive and Kidney Diseases
F31NOVEL DROSOPHILA TRANSCRIPTION FACTOR ORTHOLOG OF BCL11A/BCL11B IS CRUCIAL FOR REGULATING INTESTINAL STEM CELL QUIESCENCE AND PREVENTING GUT DYSFUNCTION DURING AGINGF31DK141194US$50.1k2025–20281 Jun 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01Coordinated Heart Stimulation Testbed: A Platform for Contractile Ventricle EngineeringR01HL169632US$383.1k2023–202825 May 2026reporter.nih.gov
National Institute of Diabetes and Digestive and Kidney Diseases
K23Mechanisms and consequences of erythritol and erythronate excess in cardiometabolic diseaseK23DK140641US$194.5k2024–202922 May 2026reporter.nih.gov
National Institute on Drug Abuse
UM1Comprehensive Somatic Variant Characterization at the HGSCUM1DA058229US$6.7m2023–202812 May 2026reporter.nih.gov
National Heart, Lung, and Blood Institute
R01Targeting Senescent Macrophages to Improve Heart Failure OutcomesR01HL179012US$627.1k2025–20308 May 2026reporter.nih.gov
R21Beyond Genetics: Unveiling Epigenetic Drivers of Lifespan Heterogeneity through Yeast Single-Cell Aging AtlasesR21AG101044US$440k2026–20285 May 2026reporter.nih.gov
P01Modifiable Drivers of Expansion and Malignant Transformation from Clonal HematopoiesisP01CA265748US$2.3m2022–20271 May 2026reporter.nih.gov
National Institute of Neurological Disorders and Stroke
R35Astrocyte Transcriptional Dependencies in Brain CircuitsR35NS132230US$925.3k2023–203127 Apr 2026reporter.nih.gov
R01Lactation on Breast TumorigenesisR01CA271588US$523.3k2023–202821 Apr 2026reporter.nih.gov
National Institute of Arthritis and Musculoskeletal and Skin Diseases
R01SPEG-Regulated Sarcoplasmic Reticulum Ca2+ Leak in Muscle Function and Disease PathophysiologyR01AR085702US$679.9k2026–203121 Apr 2026reporter.nih.gov
R01Knockin mouse models of Alzheimer's DiseaseR01AG020670US$780k2002–20277 Apr 2026reporter.nih.gov